Features
Screener
Stocks Charts
Sign In Sign Up

Fresenius Kabi Oncology Ltd. Cash Flow Statement

NSE:FKONCO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 5 years of history.

View Plans

Cash Flow Insights

Free Cash Flow

₹64.27M

FKONCO's free cash flow was ₹64.27M in FY 2013, down 89.6% from FY 2012.

CapEx Intensity

95.0%

Capital expenditure consumed 95.0% of operating cash flow in FY 2013 for FKONCO, typical of capital-intensive industries.

2-year FKONCO cash flow snapshot

Hover the chart icon for YoY change.

FY 2012 - FY 2013
Item Chart 2012 2013
Net Income 716.96M 1.15B
Cash flow Operating Activities 1.74B 1.27B
Investments in PPE -1.12B -1.21B
Cash flow Investing Activities 168.18M -1.20B
Dividend Paid 0 0
Cash flow Financing Activities 0 0
Cash at beginning of period 184.95M 131.18M
Cash at end of period 0 0
Free Cash Flow 618.66M 64.27M

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2013